SEC Form 4/A · accession 0001140361-16-090226
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John M Desmarais
Director · 10% Owner
Period of report
Dec 14, 2016
Accepted (ET)
Dec 19, 2016 · 3:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 455,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF2 | $4.50 | Dec 14, 2016 | D | 444,444 | D | — | Nov 18, 2017 | Common Stock | 444,444 | 0 | D |
| WarrantF2 | $4.50 | Dec 14, 2016 | A | 444,444 | A | — | Dec 31, 2018 | Common Stock | 444,444 | 444,444 | D |
| WarrantF3 | $5.00 | Dec 14, 2016 | D | 400,000 | D | — | Mar 18, 2018 | Common Stock | 400,000 | 0 | D |
| WarrantF3 | $5.00 | Dec 14, 2016 | A | 400,000 | A | — | Dec 31, 2018 | Common Stock | 400,000 | 400,000 | D |
| OptionF1 | $4.40 | holding | — | — | — | — | Dec 1, 2025 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $5.00 | holding | — | — | — | Dec 17, 2015 | Nov 17, 2020 | Common Stock | 125,000 | 125,000 | D |
| Warrant | $5.00 | holding | — | — | — | Mar 18, 2016 | Mar 18, 2021 | Common Stock | 250,000 | 250,000 | D |
| OptionF4 | $3.73 | holding | — | — | — | — | Jun 10, 2026 | Common Stock | 35,000 | 35,000 | D |
| WarrantF5 | $4.00 | holding | — | — | — | Jun 30, 2016 | Jun 30, 2021 | Common Stock | 40,000 | 40,000 | I |
| Warrant | $4.00 | holding | — | — | — | Sep 26, 2016 | Sep 26, 2021 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of December 1, 2016, 2017 and 2018.
- F2The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on March 18, 2016 with an expiration date of November 18, 2016 (subsequently extended to November 18, 2017). The warrant expiration date was extended to December 31, 2018.
- F3The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on March 18, 2016 with an expiration date of March 18, 2017 (subsequently extended to March 18, 2018). The warrant expiration date was extended to December 31, 2018.
- F4The option vests to the extent of 11,667 shares on each of June 10, 2016 and June 10, 2017, and 11,666 shares on June 10, 2018.
- F5The warrant is held by a trust established by the Reporting Person for the benefit of his immediate family. The Reporting Person serves as a trustee of the trust.